FY2027 EPS Estimates for INSP Decreased by Leerink Partnrs

Inspire Medical Systems, Inc. (NYSE:INSP) – Equities research analysts at Leerink Partnrs reduced their FY2027 earnings per share estimates for Inspire Medical Systems in a report issued on Monday, November 25th. Leerink Partnrs analyst M. Kratky now forecasts that the company will earn $3.57 per share for the year, down from their prior estimate of $3.63. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $1.33 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ FY2028 earnings at $5.69 EPS.

A number of other equities research analysts also recently commented on INSP. Royal Bank of Canada reiterated an “outperform” rating and issued a $260.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Truist Financial restated a “buy” rating and issued a $240.00 price target (up from $217.00) on shares of Inspire Medical Systems in a report on Monday, September 30th. Robert W. Baird increased their price target on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a report on Tuesday, November 5th. Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and increased their price target for the stock from $220.00 to $255.00 in a report on Wednesday, November 20th. Finally, Wells Fargo & Company increased their price target on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $233.58.

Inspire Medical Systems Trading Down 5.2 %

NYSE INSP opened at $189.05 on Tuesday. The stock has a 50-day simple moving average of $199.01 and a 200 day simple moving average of $175.73. The company has a market capitalization of $5.67 billion, a PE ratio of 176.68 and a beta of 1.36. Inspire Medical Systems has a 12 month low of $123.00 and a 12 month high of $257.40.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. The business had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The firm’s revenue was up 32.6% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.29) earnings per share.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Synovus Financial Corp boosted its position in Inspire Medical Systems by 7.5% during the third quarter. Synovus Financial Corp now owns 3,502 shares of the company’s stock valued at $739,000 after purchasing an additional 244 shares during the last quarter. Tidal Investments LLC acquired a new stake in shares of Inspire Medical Systems in the third quarter valued at approximately $320,000. Teachers Retirement System of The State of Kentucky lifted its position in shares of Inspire Medical Systems by 20.1% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 49,178 shares of the company’s stock valued at $10,379,000 after buying an additional 8,240 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Inspire Medical Systems by 0.7% in the third quarter. Geode Capital Management LLC now owns 483,654 shares of the company’s stock valued at $102,102,000 after buying an additional 3,128 shares during the last quarter. Finally, M&T Bank Corp lifted its position in shares of Inspire Medical Systems by 53.1% in the third quarter. M&T Bank Corp now owns 3,228 shares of the company’s stock valued at $681,000 after buying an additional 1,120 shares during the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Inspire Medical Systems

In related news, Director Shawn Mccormick sold 800 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $220.00, for a total transaction of $176,000.00. Following the completion of the transaction, the director now directly owns 23,140 shares of the company’s stock, valued at approximately $5,090,800. This represents a 3.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 4.10% of the stock is owned by insiders.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.